Table 1.
Characteristics of 97 subjects (Max n= 946)
| Characteristic | Mean ± SD or N (%) |
|---|---|
| Age (years) ± SD | 74.8 ± 7.5 |
| BMI (kg/m2) ± SD | 28.1 ± 5.6 |
| Overweight (25–29.9) | 34 (35.1) |
| Obesity (≥30) | 31 (32.0) |
| Male | 25 (25.8) |
| Former smoker | 42 (43.3) |
| Cardiovascular Disease | 16 (16.5) |
| Hypertension | 66 (68.0) |
| Hypercholesterolemia (by history) | 52 (53.6) |
| Lipid Profile | |
| Total cholesterol | 188.7 ± 44.7 |
| > 200 mg/dL | 47 (48.5) |
| LDL-C | 116.4 ± 36.7 |
| > 130 mg/dL | 30 (30.9) |
| HDL-C | 55.2 ± 18.5 |
| Female <50 mg/dL, male <40 mg/dL | 32 (33.0) |
| Adult-onset Diabetes Mellitus | 22 (22.7) |
| COPD | 8 (8.3) |
| Asthma | 12 (12.4) |
| Medications | |
| Anti-hypertensive medication | 63 (65.0) |
| HMG-CoA reductase inhibitors (statins) | 45 (46.4) |
| Biomarkers | |
| IL-6 (pg/mL; n=716) | 2.4 ± 1.7 |
| oxLDL (U/L; n=841) | 59.2 ± 20.2 |
| FeNO (ppb; n=901) | 26.6 ± 13.4 |
| EBC MDA (nmol; n=643) | 8.4 ± 5.1 |
Abbreviations: BMI, body mass index; COPD: chronic obstructive pulmonary disease; EBC: exhaled breath condensate; MDA: malondialdehyde.